International Stroke Conference 2025  /  Optimal Imaging for Patient Triage in the Late Time Window and with Large Cores? (Debate)  /  NCCT and CTA is all that is needed to triage MeVO
Logo

American Heart Association

  9
  0

Final ID:

NCCT and CTA is all that is needed to triage MeVO

  • Psychogios, Marios  ( University Hospital Basel , Basel , Switzerland )
  • Clarencon, Frederic  ( Hôpitaux Universitaires Pitié Salpêtrière , Paris , France )
    • Author Disclosures:
    Marios Psychogios: DO have relevant financial relationships ; Research Funding (PI or named investigator):Penumbra Inc.:Active (exists now) ; Research Funding (PI or named investigator):Rapid Medical Inc.:Active (exists now) ; Research Funding (PI or named investigator):Phenox GmbH:Active (exists now) ; Research Funding (PI or named investigator):Stryker Neurovascular Inc.:Active (exists now) ; Research Funding (PI or named investigator):Medtronic Inc.:Active (exists now) ; Research Funding (PI or named investigator):Siemens Healthineers AG:Active (exists now) ; Speaker:Siemens Healthineers AG:Active (exists now) ; Speaker:Phenox GmbH:Active (exists now) ; Speaker:Penumbra Inc.:Active (exists now) ; Speaker:Medtronic Inc.:Active (exists now) ; Speaker:Stryker Neurovascular Inc.:Active (exists now) | Frederic Clarencon: No Answer
Meeting Info:

International Stroke Conference 2025

2025

Los Angeles, CA

Session Info:

Optimal Imaging for Patient Triage in the Late Time Window and with Large Cores? (Debate)

Thursday, 02/06/2025 , 09:15AM - 10:45AM

ISC Debate

More abstracts on this topic:
CTP or MRI is needed to triage MeVO

Muir Keith

CTP or MRI is Needed to Triage Late-Time Window Strokes

Albers Greg, Thomalla Goetz

More abstracts from these authors:
Q&A Session: Mechanical Thrombectomy in Acute Ischemic Stroke Related to a Distal Arterial Occlusion: Interim Analysis of the DISCOUNT Randomized Controlled Trial (LB47)

Clarencon Frederic

Mechanical Thrombectomy in Acute Ischemic Stroke Related to a Distal Arterial Occlusion: Interim Analysis of the DISCOUNT Randomized Controlled Trial

Clarencon Frederic

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.

   Rate this abstract  (Maximum characters: 500)